Lipid Modification for the Prevention of Cardiovascular Disease (NICE Guideline)

Summary of NICE guidance on lipid lowering with statins.

 Download a pdf version of the above chart.

Adapted from: NICE Clinical Guideline 181 (July 2014; updated July 2016) - Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

 


KEYWORDS: Acute coronary syndrome | Cardiovascular risk assessment | Lipid modification | Primary prevention of CVD | Secondary prevention of CVD | Statins


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more